Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsAer-IgY in Cystic Fibrosis
NCT01455675Phase 3Completed
- Sponsor
- Mukoviszidose Institut
- Start
- Oct 2011
- Primary completion
- Jun 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 3 trial of anti-pseudomonas IgY in Pseudomonas aeruginosa infection, sponsored by Mukoviszidose Institut. Started Oct 2011; status: completed.
02
Drugs
anti-pseudomonas IgY
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01455675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455675.